Discrepancies between guidelines and clinical practice regarding prostate-specific antigen testing

Abstract

From 2002 to 2011, PSA incidence testing rates increased, particularly in men with urinary symptoms and cardiovascular disease, despite several international guidelines that suggest a judicious use of PSA tests.